Literature DB >> 23947984

A systematic literature review of psychosocial and behavioral factors associated with initial medication adherence: a report of the ISPOR medication adherence & persistence special interest group.

John E Zeber1, Elizabeth Manias, Allison F Williams, David Hutchins, Waka A Udezi, Craig S Roberts, Andrew M Peterson.   

Abstract

OBJECTIVES: Numerous factors influencing medication adherence in chronically ill patients are well documented, but the paucity of studies concerning initial treatment course experiences represents a significant knowledge gap. As interventions targeting this crucial first phase can affect long-term adherence and outcomes, an international panel conducted a systematic literature review targeting behavioral or psychosocial risk factors.
METHODS: Eligible published articles presenting primary data from 1966 to 2011 were abstracted by independent reviewers through a validated quality instrument, documenting terminology, methodological approaches, and factors associated with initial adherence problems.
RESULTS: We identified 865 potentially relevant publications; on full review, 24 met eligibility criteria. The mean Nichol quality score was 47.2 (range 19-74), with excellent reviewer concordance (0.966, P < 0.01). The most prevalent pharmacotherapy terminology was initial, primary, or first-fill adherence. Articles described the following factors commonly associated with initial nonadherence: patient characteristics (n = 16), medication class (n = 12), physical comorbidities (n = 12), pharmacy co-payments or medication costs (n = 12), health beliefs and provider communication (n = 5), and other issues. Few studies reported health system factors, such as pharmacy information, prescribing provider licensure, or nonpatient dynamics.
CONCLUSIONS: Several methodological challenges synthesizing the findings were observed. Despite implications for continued medication adherence and clinical outcomes, relatively few articles directly examined issues associated with initial adherence. Notwithstanding this lack of information, many observed factors associated with nonadherence are amenable to potential interventions, establishing a solid foundation for appropriate ongoing behaviors. Besides clarifying definitions and methodology, future research should continue investigating initial prescriptions, treatment barriers, and organizational efforts to promote better long-term adherence.
Copyright © 2013 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  behavioral risk factors; first fill medication adherence; initial medication adherence; primary medication adherence; systematic review

Mesh:

Year:  2013        PMID: 23947984     DOI: 10.1016/j.jval.2013.04.014

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  26 in total

1.  Medication non-adherence after myocardial infarction: an exploration of modifying factors.

Authors:  Matthew J Crowley; Leah L Zullig; Bimal R Shah; Ryan J Shaw; Jennifer H Lindquist; Eric D Peterson; Hayden B Bosworth
Journal:  J Gen Intern Med       Date:  2015-01       Impact factor: 5.128

2.  Affective forecasting and medication decision making in breast-cancer prevention.

Authors:  Michael Hoerger; Laura D Scherer; Angela Fagerlin
Journal:  Health Psychol       Date:  2016-02-11       Impact factor: 4.267

Review 3.  Systematic Review of Clinical Practice Guidelines for the Improvement of Medication Adherence.

Authors:  Todd M Ruppar; Fabienne Dobbels; Pawel Lewek; Michal Matyjaszczyk; Kaat Siebens; Sabina M De Geest
Journal:  Int J Behav Med       Date:  2015-12

4.  Novel application of approaches to predicting medication adherence using medical claims data.

Authors:  Leah L Zullig; Shelley A Jazowski; Tracy Y Wang; Anne Hellkamp; Daniel Wojdyla; Laine Thomas; Lisa Egbuonu-Davis; Anne Beal; Hayden B Bosworth
Journal:  Health Serv Res       Date:  2019-08-20       Impact factor: 3.402

5.  Buprenorphine Treatment and Patient Use of Health Services after the Affordable Care Act in an Integrated Health Care System.

Authors:  Cynthia I Campbell; Sujaya Parthasarathy; Kelly C Young-Wolff; Derek D Satre
Journal:  J Psychoactive Drugs       Date:  2017-04-20

6.  Improving adherence to high-value medications through prescription cost-sharing policies.

Authors:  Melissa M Garrido; Austin B Frakt
Journal:  BMJ Qual Saf       Date:  2018-04-19       Impact factor: 7.035

7.  Association between interpersonal continuity of care and medication adherence in type 2 diabetes: an observational cohort study.

Authors:  Anara Richi Dossa; Jocelyne Moisan; Line Guénette; Sophie Lauzier; Jean-Pierre Grégoire
Journal:  CMAJ Open       Date:  2017-05-08

8.  A systematic review of the inclusion of mechanisms of action in NIH-funded intervention trials to improve medication adherence.

Authors:  Donald Edmondson; Louise Falzon; Kevin J Sundquist; Jacob Julian; Laura Meli; Jennifer A Sumner; Ian M Kronish
Journal:  Behav Res Ther       Date:  2017-10-05

Review 9.  Why estrogens matter for behavior and brain health.

Authors:  Liisa A M Galea; Karyn M Frick; Elizabeth Hampson; Farida Sohrabji; Elena Choleris
Journal:  Neurosci Biobehav Rev       Date:  2016-03-31       Impact factor: 8.989

10.  Impact of initial medication non-adherence on use of healthcare services and sick leave: a longitudinal study in a large primary care cohort in Spain.

Authors:  Ignacio Aznar-Lou; Ana Fernández; Montserrat Gil-Girbau; Ramón Sabés-Figuera; Marta Fajó-Pascual; María Teresa Peñarrubia-María; Antoni Serrano-Blanco; Patricia Moreno-Peral; Albert Sánchez-Niubó; Marian March-Pujol; Maria Rubio-Valera
Journal:  Br J Gen Pract       Date:  2017-07-31       Impact factor: 5.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.